The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up Study.

Inclusion Criteria:

• Boys or girls, 6 months to 6 years of age;

• With one of his/her parents/legal guardian purchases Petit Drill in a participatingpharmacy in accordance with recommendations for use (regarding age and type ofcough);

• For infants between 6 months and 12 months of age - a confirmed prescription from atreating physician;

• With an acute cough lasting less than 48 hours

• With a score ≥ 3 at least for 3 of the 5 items of PCQ, (based on assessment of thenight before inclusion);

• For whom child-minding will allow to respect the recommended daily doses of PetitDrill during the 3 day-treatment;

• With a parent/legal guardian having a smartphone allowing using the ePRO App.NursTrial®;

• With a parent/legal guardian able to understand and to complete to thequestionnaires in timely manner;

• With parent(s)/legal guardian who provide their signed informed consent for thechild's enrolment in the study.

Exclusion Criteria:

• Presenting with one of the following conditions: Chronic respiratory illness such asasthma, recurrent wheezing associated to viral infections and bronchitis or lowerrespiratory infections, such as bronchitis, bronchiolitis, and pneumonia or angina,otitis, or sinusitis or persistent cough lasting more than 3 weeks, whatever theetiology or gastrointestinal pathology, involving vomiting, nausea, or diarrhoea.

• With ongoing use of paracetamol, and/or homeopathic products against cough.

• Having had corticosteroid treatment, antibiotics, antihistaminic or any coughmedication (such as, but not limited to, Phytoxil, Arkotoux) in the previous 15 dayssince inclusion.

• With a brother/sister already included in the present clinical investigation (Ifseveral children are eligible in the same household, only one will be enrolled atrandom).

• Enrolled in another clinical trial or being in a period of exclusion from a previousclinical trial.